Adjuvant Therapy for Stage II Colon Cancer: Prognostic and Predictive Markers

Publisher： Cambridge Scholars Publishing in association with GSE Research

ISSN： 1540-1405

Source： Journal of the National Comprehensive Cancer Network (JNCCN), Vol.5, Iss.9, 2007-10, pp. : 927-936

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Prognostic importance of VEGF-A haplotype combinations in a stage II colon cancer population

By Kjaer-Frifeldt Sanne Fredslund Rikke Lindebjerg Jan Hansen Torben Froestrup Spindler Karen-Lise Garm Jakobsen Anders

Pharmacogenomics, Vol. 13, Iss. 7, 2012-05 ,pp. : 763-770

Future Medicine

Access to resources Recommend Favorite

Adjuvant chemotherapy use and outcomes of patients with high-risk versus low-risk stage II colon cancer

By Kumar Aalok Kennecke Hagen F. Renouf Daniel J. Lim Howard J. Gill Sharlene Woods Ryan Speers Caroline Cheung Winson Y.

Cancer, Vol. 121, Iss. 4, 2015-02 ,pp. : 527-534

Blackwell Publishing

Access to resources Recommend Favorite

Adjuvant Therapy for Early Colon Cancer: Current Status

By Stein Alexander

Drugs, Vol. 71, Iss. 17, 2011-12 ,pp. : 2257-2275

Adis International

Access to resources Recommend Favorite

Prognostic and Predictive Markers in Colorectal Cancer - The Role of New Genomic Technologies

Current Pharmacogenomics, Vol. 5, Iss. 4, 2007-12 ,pp. : 255-261

Bentham Science Publishers

Access to resources Recommend Favorite

Base Excision Repair Factors are Promising Prognostic and Predictive Markers in Cancer

Current Molecular Pharmacology, Vol. 5, Iss. 1, 2012-01 ,pp. : 115-124

Bentham Science Publishers

Access to resources Recommend Favorite